VYNE
Vyne Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$22.36M
P/E Ratio
—
EPS
$-0.51
Beta
2.01
52W High
$1.59
52W Low
$0.28
50-Day MA
$0.66
200-Day MA
$0.54
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vyne Therapeutics Inc
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. The company is headquartered in Bridgewater, New Jersey.
Fundamentals
| Revenue (TTM) | 454,000 |
| Gross Profit (TTM) | 454,000 |
| EBITDA | $-24.34M |
| Operating Margin | -4437.00% |
| Return on Equity | -63.20% |
| Return on Assets | -37.00% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.74 |
| Price-to-Book | 0.92 |
| Price-to-Sales (TTM) | 49.25 |
| EV/Revenue | 10.04 |
| EV/EBITDA | 1.84 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -57.40% |
| Shares Outstanding | $33.39M |
| Float | $30.59M |
| % Insiders | 10.12% |
| % Institutions | 39.58% |
Historical Volatility
HV 10-Day
30.66%
HV 20-Day
31.18%
HV 30-Day
27.97%
HV 60-Day
24.03%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($2.00 target)
1
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 7/9/2026